EU regulator says no clot risk factor yet linked to AstraZeneca vaccine
The vaccine's benefits outweigh the risks, the European Medicines Agency reiterated, but cautioned that people should be aware of the remote possibility of rare blood clots occurring, and must seek immediate medical attention in case of symptoms
AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. Photo :Reuters
Europe's medicines regulator said on Wednesday it had not yet identified any risk factors such as age, sex or a previous history of blood clotting disorders, for clotting cases reported after inoculation with AstraZeneca's Covid-19 vaccine.
The vaccine's benefits outweigh the risks, the European Medicines Agency reiterated, but cautioned that people should be aware of the remote possibility of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.
Keep updated, follow The Business Standard's Google news channel
